Cargando…
The Promotion of Humoral Immune Responses in Humans via SOCS1-Mediated Th2-Bias Following SARS-CoV-2 Vaccination
The effectiveness of SARS-CoV-2 vaccines varies among individuals. During the COVID-19 global pandemic, SARS-CoV-2 infection showed significant Th1 characteristics, suggesting that the immune disorder and production of SARS-CoV-2 antibodies may be related to Th1/Th2 bias. However, the molecular mech...
Autores principales: | Liu, Xiaoyu, Han, Junyong, Cui, Renjie, Peng, Meifang, Song, Huaidong, Li, Rui, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674672/ https://www.ncbi.nlm.nih.gov/pubmed/38006062 http://dx.doi.org/10.3390/vaccines11111730 |
Ejemplares similares
-
Systematic profiling of antigen bias in humoral response against SARS-CoV-2
por: Wei, Nana, et al.
Publicado: (2022) -
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
por: Wei, Jia, et al.
Publicado: (2020) -
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022) -
Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022) -
Recombinant protein subunit SARS-CoV-2 vaccines formulated with
CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses
in mice
por: Lai, Chih-Yun, et al.
Publicado: (2021)